Mark R. Sullivan

2.1k total citations · 1 hit paper
13 papers, 1.1k citations indexed

About

Mark R. Sullivan is a scholar working on Cancer Research, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Mark R. Sullivan has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Mark R. Sullivan's work include Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Mark R. Sullivan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (7 papers), Epigenetics and DNA Methylation (4 papers) and Tuberculosis Research and Epidemiology (3 papers). Mark R. Sullivan collaborates with scholars based in United States and Germany. Mark R. Sullivan's co-authors include Matthew G. Vander Heiden, Katherine Mattaini, Caroline A. Lewis, Alexander Muir, Emily A. Dennstedt, Tenzin Kunchok, Sze Ham Chan, Dan Y. Gui, Laura V. Danai and Alicia M. Darnell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Nature Cell Biology.

In The Last Decade

Mark R. Sullivan

13 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability

2019 368 citations Mark R. Sullivan, Laura V. Danai et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark R. Sullivan United States	10	733	551	250	155	148	13	1.1k
Le Li China	17	559 0.8×	337 0.6×	301 1.2×	168 1.1×	49 0.3×	46	1.0k
Reza Beheshti Zavareh United States	12	626 0.9×	254 0.5×	242 1.0×	136 0.9×	88 0.6×	15	929
Kiran Kurmi United States	11	596 0.8×	399 0.7×	191 0.8×	223 1.4×	27 0.2×	16	1.0k
Chunjing Wu United States	19	540 0.7×	278 0.5×	315 1.3×	150 1.0×	51 0.3×	38	1.0k
Cheng-Ying Chu Taiwan	13	478 0.7×	340 0.6×	118 0.5×	129 0.8×	25 0.2×	18	768
Mingyao Huang China	15	565 0.8×	386 0.7×	129 0.5×	192 1.2×	58 0.4×	20	918
Paola Campomenosi Italy	20	768 1.0×	376 0.7×	350 1.4×	51 0.3×	38 0.3×	51	1.1k
Marten Hornsveld Netherlands	13	811 1.1×	325 0.6×	366 1.5×	83 0.5×	19 0.1×	20	1.2k
Carsten P. Ade Germany	18	708 1.0×	193 0.4×	321 1.3×	90 0.6×	34 0.2×	35	1.0k
Kirill V. Rosen Canada	19	875 1.2×	183 0.3×	330 1.3×	130 0.8×	30 0.2×	37	1.2k

Countries citing papers authored by Mark R. Sullivan

Since Specialization

Citations

This map shows the geographic impact of Mark R. Sullivan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark R. Sullivan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark R. Sullivan more than expected).

Fields of papers citing papers by Mark R. Sullivan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark R. Sullivan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark R. Sullivan. The network helps show where Mark R. Sullivan may publish in the future.

Co-authorship network of co-authors of Mark R. Sullivan

This figure shows the co-authorship network connecting the top 25 collaborators of Mark R. Sullivan. A scholar is included among the top collaborators of Mark R. Sullivan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark R. Sullivan. Mark R. Sullivan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Wang, Xin, et al.. (2025). Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in Mycobacterium abscessus. PLoS Pathogens. 21(4). e1013027–e1013027. 4 indexed citations

Sullivan, Mark R., Qiang Liu, David C. Young, et al.. (2023). Biotin-dependent cell envelope remodelling is required for Mycobacterium abscessus survival in lung infection. Nature Microbiology. 8(3). 481–497. 18 indexed citations

Sullivan, Mark R., et al.. (2023). Mutation rates and adaptive variation among the clinically dominant clusters of Mycobacterium abscessus. Proceedings of the National Academy of Sciences. 120(22). e2302033120–e2302033120. 7 indexed citations

Badeaux, Mark, Annah S. Rolig, Melissa J. Kasiewicz, et al.. (2021). Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth. Cancer Immunology Research. 9(4). 415–429. 15 indexed citations

Sullivan, Mark R., Alicia M. Darnell, Tenzin Kunchok, et al.. (2021). Methionine synthase is essential for cancer cell proliferation in physiological folate environments. Nature Metabolism. 3(11). 1500–1511. 65 indexed citations

Dalin, Simona, Mark R. Sullivan, Allison N. Lau, et al.. (2019). Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance. Cancer Research. 79(22). 5723–5733. 93 indexed citations

Sullivan, Mark R., Caroline A. Lewis, & Alexander Muir. (2019). Isolation and Quantification of Metabolite Levels in Murine Tumor Interstitial Fluid by LC/MS. BIO-PROTOCOL. 9(22). e3427–e3427. 7 indexed citations

Sullivan, Mark R., Katherine Mattaini, Emily A. Dennstedt, et al.. (2019). Increased Serine Synthesis Provides an Advantage for Tumors Arising in Tissues Where Serine Levels Are Limiting. Cell Metabolism. 29(6). 1410–1421.e4. 175 indexed citations

Sullivan, Mark R., Laura V. Danai, Caroline A. Lewis, et al.. (2019). Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife. 8. 368 indexed citations breakdown →

10.

Mattaini, Katherine, Mark R. Sullivan, Allison N. Lau, et al.. (2019). Increased PHGDH expression promotes aberrant melanin accumulation. BMC Cancer. 19(1). 723–723. 10 indexed citations

11.

Sullivan, Mark R. & Matthew G. Vander Heiden. (2019). Determinants of nutrient limitation in cancer. Critical Reviews in Biochemistry and Molecular Biology. 54(3). 193–207. 41 indexed citations

12.

Sullivan, Mark R. & Matthew G. Vander Heiden. (2017). When cancer needs what's non-essential. Nature Cell Biology. 19(5). 418–420. 13 indexed citations

13.

Mattaini, Katherine, Mark R. Sullivan, & Matthew G. Vander Heiden. (2016). The importance of serine metabolism in cancer. The Journal of Cell Biology. 214(3). 249–257. 295 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact